1-15495402-A-C

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate

The NM_001229.5(CASP9):ā€‹c.919T>Gā€‹(p.Ser307Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000687 in 1,455,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S307Y) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 29)
Exomes š‘“: 6.9e-7 ( 0 hom. )

Consequence

CASP9
NM_001229.5 missense

Scores

19

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.101
Variant links:
Genes affected
CASP9 (HGNC:1511): (caspase 9) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.047035605).
BP6
Variant 1-15495402-A-C is Benign according to our data. Variant chr1-15495402-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 3485274.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CASP9NM_001229.5 linkc.919T>G p.Ser307Ala missense_variant 7/9 ENST00000333868.10 NP_001220.2 P55211-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CASP9ENST00000333868.10 linkc.919T>G p.Ser307Ala missense_variant 7/91 NM_001229.5 ENSP00000330237.5 P55211-1

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD3 exomes
AF:
0.00000418
AC:
1
AN:
239098
Hom.:
0
AF XY:
0.00000774
AC XY:
1
AN XY:
129262
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000559
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.87e-7
AC:
1
AN:
1455280
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
723296
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000253
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
29
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 06, 2024This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
0.097
DANN
Benign
0.32
DEOGEN2
Benign
0.058
.;T;.;.;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.42
T;T;T;T;T
M_CAP
Benign
0.0017
T
MetaRNN
Benign
0.047
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.030
.;N;.;.;.
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.58
N;N;N;N;N
REVEL
Benign
0.034
Sift
Benign
0.44
T;T;T;T;T
Sift4G
Benign
0.53
T;T;T;T;.
Polyphen
0.0010
B;B;B;.;.
Vest4
0.080
MutPred
0.30
Loss of phosphorylation at S307 (P = 0.0067);Loss of phosphorylation at S307 (P = 0.0067);.;.;.;
MVP
0.18
MPC
0.098
ClinPred
0.030
T
GERP RS
-9.3
Varity_R
0.017
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs750849037; hg19: chr1-15821897; API